Dr. AriMelnick

Dr. Ari M. Melnick, MD, is a world-leading medical oncologist and global authority in hematologic malignancies and cancer epigenetics. He serves as the Gebroe Family Professor of Hematology and Oncology and Chair of the Hematologic Malignancies Program at Weill Cornell Medicine. Dr. Melnick earned his medical degree from the University of Buenos Aires, completed his residency in Internal Medicine and fellowship in Hematology and Oncology at Mount Sinai Medical Center, and pursued postdoctoral research in molecular oncology at Memorial Sloan Kettering Cancer Center. He is board-certified in Internal Medicine, Hematology, and Medical Oncology and is widely recognized for his leadership in advancing epigenetic therapies for lymphoma and leukemia.